Science
Mechanism of Action
The efficacy of Eugenia Caryophyllus Bud Oil is largely attributed to its primary component, Eugenol (75-90%), and β-caryophyllene. Eugenol acts as a potent antioxidant, neutralizing oxygenated radicals that contribute to premature skin aging, and provides significant antimicrobial defense against pathogens like *Staphylococcus aureus* and *Cutibacterium acnes*. Both Eugenol and β-caryophyllene effectively interrupt inflammatory cascades, leading to a reduction in redness and swelling. The oil further supports skin health by stimulating microcirculation, which enhances nutrient delivery and contributes to a healthier, more radiant complexion, and by actively promoting collagen synthesis vital for tissue repair and anti-aging processes.
Research
Clinical Evidence
High confidenceFor cellular benefits, concentrations between 0.00156% (for collagen synthesis) and 0.011% (for anti-inflammatory and antiproliferative effects) demonstrate significant activity. For targeted symptomatic relief like chronic itching, higher concentrations up to 2.5% (when diluted for normal skin) have been utilized.
Key findings
- 01 Demonstrated robust antiproliferative effects on human dermal fibroblasts and significantly inhibited the increased production of proinflammatory biomarkers (e.g., VCAM-1, IP-10). It also significantly inhibited tissue remodeling protein molecules (e.g., collagen-I, collagen-III) and modulated gene expression critical for inflammation and tissue remodeling.
- 02 Significantly increased collagen synthesis and suggested potential anti-aging and skin whitening effects due to its antityrosinase activity in vitro.
- 03 Topical application in a cream significantly relieved chronic itching. A study also reported a 60% healing rate in individuals with anal fissures compared to 12% in control groups.
Transparency
Dusting Analysis
This ingredient is not commonly 'dusted' for marketing. Its primary active component, Eugenol, is potent and regulated, requiring label declaration above specific concentrations, indicating its intentional inclusion for its documented effects or fragrance.
The Formula
Formulation
Safety
Safety Profile
Eugenol, comprising 75-90% of Eugenia Caryophyllus Bud Oil, is a well-known skin sensitizer and is regulated under IFRA Standards (Amendment 51) and EU Cosmetics Regulation 2023/1545. High concentrations or undiluted use can cause severe irritation, burning, sensitization, contact dermatitis, inflammation, and rashes, potentially leading to permanent skin cell damage. Eugenol's presence must be declared on product labels when concentrations exceed 0.001% in leave-on products and 0.01% in rinse-off products. It is not recommended for children under 5, individuals with compromised skin barriers, eczema, rosacea, or those experiencing frequent irritation. Essential patch testing is crucial, especially for sensitive or acne-prone skin. Avoid use near eyes, lips, nostrils, or mucous membranes.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite its promising antioxidant, anti-inflammatory, and collagen-boosting benefits demonstrated at low concentrations, the high irritancy and significant sensitization risk, primarily due to Eugenol, make Eugenia Caryophyllus Bud Oil a questionable ingredient for general skincare formulations, particularly for sensitive skin types.
Related
Similar Ingredients
Finding similar ingredients…